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Abstract
Purpose Laparoscopic rectal surgery in obese patients is technically challenging. The technological advantages of robotic
instruments can help overcome some of those challenges, but whether this translates to superior short-term outcomes is largely
unknown. The aim of this study is to compare the short-term surgical outcomes of obese (BMI ≥ 30) robotic and laparoscopic
rectal cancer surgery patients.
Methods All consecutive obese patients receiving laparoscopic and robotic rectal cancer resection surgery from three centres,
two from the UK and one from Portugal, between 2006 and 2017 were identified from prospectively collated databases. Robotic
surgery patients were propensity score matched with laparoscopic patients for ASA grade, neoadjuvant radiotherapy and path-
ological T stage. Their short-term outcomes were examined.
Results A total of 222 patients were identified (63 robotic, 159 laparoscopic). The 63 patients who received robotic surgery were
matched with 61 laparoscopic patients. Cohort characteristics were similar between the two groups. In the robotic group,
operative time was longer (260 vs 215 min; p = 0.000), but length of stay was shorter (6 vs 8 days; p = 0.014), and thirty-day
readmission rate was lower (6.3% vs 19.7%; p = 0.033).
Conclusions In this study population, robotic rectal surgery in obese patients resulted in a shorter length of stay and lower 30-day
readmission rate but longer operative time when compared to laparoscopic surgery. Robotic rectal surgery in the obese may be
associated with a quicker post-operative recovery and reduced morbidity profile. Larger-scale multi-centre prospective observa-
tional studies are required to validate these results.
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Introduction
Laparoscopic colorectal surgery has become the new standard
for colorectal diseases as it offers several advantages over
open surgery such as shorter hospital stay, earlier return to
normal function, less postoperative pain, early mobilisation
and improved cosmesis [1–6]. There is consensus amongst
surgeons that obesity increases the technical difficulty of co-
lorectal surgery [7, 8]. Obese patients tend to have a thickened
and excessive omentum and mesentery which restricts the
space for instrumental manoeuvre, limits access and vision,
distorts the surgical planes and can lead to problematic bleed-
ing [9]. With obesity becoming increasingly a major hazard to
public health worldwide, colorectal surgeons are likely to en-
counter and operate on this group of patients in increasing
numbers [10, 11].
Laparoscopic rectal surgery is particularly demanding, with
studies reporting high conversion rates for rectal surgery and
two recent multi-centre randomised control trials (ALaCaRT
and ACOSOG Z6051) failing to show that laparoscopic
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surgery is non-inferior to open surgery [4, 12–14]. This is
because existing laparoscopic instruments have a restricted
range of movement compared with that of the surgeons hand
and are difficult to use in confined spaces such as the bony
pelvis [15, 16]. These limitations are magnified in the obese
due to the even greater restriction of available space for ma-
noeuvre in this group of patients.
Robotic surgical systems were designed to overcome the
limitations of laparoscopic surgery by providing stable
three-dimensional views from a surgeon-controlled camera,
angulated instruments with 7° of freedom,markedly improved
ergonomics and tremor filtering [15, 17]. These advantages
are particularly attractive in rectal surgery, overcoming the
challenges of laparoscopic instrumentation and technique in
obese patients, where space is limited and accurate dissection
in narrow deep cavities is required. However, whether robotic
rectal surgery in the obese translates to superior short-term
surgical outcomes is hitherto poorly examined. At present,
there are only two studies comparing the short-term surgical
outcomes of obese patients having laparoscopic and robotic
rectal surgery [18, 19], with both studies including smaller
sample sizes.
The aim of this study is to build upon current evidence by
analysing and comparing the short-term surgical outcomes of
obese patients undergoing robotic and laparoscopic rectal re-
section surgery.
Methods
A retrospective analysis of prospectively maintained data-
bases was conducted for this study. Consecutive patients from
three centres, two from the UK and one from Portugal, who
received minimally invasive rectal cancer surgical resections
between 2006 and 2017 were identified. The inclusion criteria
included all obese patients (defined as patients with a BMI ≥
30) receiving laparoscopic or robotic elective rectal resection
surgery. The robotic cases were propensity score matched to
laparoscopic cases to obtain comparable patients.
All cancer patients were discussed in a multidisciplinary
team meeting (MDT) prior to initiating any type of treatment.
Magnetic resonance imaging (MRI) scans were reported using
theMercury criteria, and preoperative chemoradiotherapy was
given to patients with high risk for local recurrence (threat-
ened circumferential resection margin ≤ 2mm or T4 in staging
MRI). Neo-adjuvant radiotherapy was not used where rectal
cancers were considered resectable by total mesorectal exci-
sion (TME) with a likelihood of clear margins.
No specific selection criteria were used to allocate patients
to laparoscopic or robotic surgery. Applied surgical modality
was based on equipment and theatre availability. The robotic
approach was the preferred approach following the adoption
of robotic surgery in each unit. This was fromMay 2013 (Unit
A), November 2015 (Unit B) and May 2016 (Unit C) for each
unit, respectively. All recruited patients signed an informed
consent form allowing their data to be used for analysis and
its publishing. The requirements for anonymization of person-
al dataset by the Data Protection Act 1998 were satisfied.
According to the Health Research Authority (HRA), this
study did not require their approval due to its status as a clin-
ical audit.
Patients included in the study had surgery performed by fully
trained laparoscopic and robotic colorectal surgeons. The sur-
geon from one of the centres (surgeon AP) led a supervised
training programme involving the remaining surgeons participat-
ing in this study, ensuring that the same standardised modular
approach was used throughout. Data collection commenced
when the participating surgeons began working in their respec-
tive units, between 2006 and 2012 for the UK centres and 2013
for the Portuguese centre. In addition, 15 robotic cases performed
by surgeon AP in other centres as part of demonstrating/
proctoring cases were included in the study.
Surgical technique
A previously described, standardised modular approach was
used for laparoscopic surgery [20, 21]. Medial to lateral colonic
mobilisation with isolation of the main vessels using clips was
applied followed by TME using monopolar diathermy [20, 21].
Robotic rectal resections were performed using a single
docking fully robotic approach [22–24]. The da Vinci Si was
used in one of the UK centres and the da Vinci Xi coupled
with table motion in the remaining two centres. The principle
of standardised technique developed for laparoscopic surgery
was also used for robotic surgery. Procedures commenced
with medial to lateral dissection followed by vascular control
by ligating the main vessels. A three-step approach was used
for splenic flexure mobilisation [25]. Patients with upper rec-
tal tumours (10–15 cm from anal verge) received partial
mesorectal excisions (PME), while all patients with tumours
below 10 cm (i.e. for mid- and low-rectal tumours) received
TMEs. TME was performed in the same stepwise manner as
in the laparoscopic group, starting with posterior mobilisation
followed by right lateral, anterior and left lateral mobilisation
in a stepwise manner. All patients receiving complete TME
surgery were given pre-operative bowel preparation the day
before surgery and had loop ileostomies fashioned in cases
where an anastomosis was formed. Postoperatively, all pa-
tients were managed using the enhanced recovery program
described by Kehlet and Wilmore [26]. Patients were
discharged home according to set criteria for discharge.
Data collection and outcome assessment
The cohort characteristics and short-term surgical outcomes of
obese patients receiving elective robotic and laparoscopic
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rectal surgery were analysed. Cohort characteristics analysed
included age, BMI, gender, American Society of
Anaesthesiologist (ASA) grade, neoadjuvant radiotherapy,
operation performed and pathological T stage. Peri-operative
data included operative time, estimated blood loss and con-
version to open (defined as any incision needed to either mo-
bilise the colon or rectum or ligate the vessels). Post-operative
clinical data examined included length of stay, 30-day read-
mission, 30-day reoperation, 30-day mortality and anastomot-
ic leak. Pathological data examined included lymph node
yield and circumferential resection margin (CRM) clearance.
Statistical analysis
Once collated, cleaned and checked data was analysed using
IBM SPSS version 24 (SPSS Inc., Chicago, IL, USA). The
robotic cases were propensity scored matched to laparoscopic
cases. The variables used to calculate the propensity score
matching were as follows: neoadjuvant radiotherapy (yes vs
no), ASA grade (I, II vs III, IV) and p T stage (T0–2 vs T3–4).
Propensity scores were calculated via logistic regression anal-
ysis by applying the Propensity Score Matching function on
SPSS version 24 with the match tolerance set to 0.4.
Non-parametric data was expressed as median with inter-
quartile range and parametric data as mean with standard de-
viation. Cohort demographic and clinical characteristics were
compared using χ2 test or Fishers exact test for categorical
variables, Mann-Whitney U test for non-parametric continu-
ous variables and t test for parametric continuous variables. P
values of < 0.05 were considered statistically significant.
Finally, univariate binary logistic regression analysis was
performed on all obese patients receiving elective minimally
invasive rectal surgery to assess whether surgical approach
(robotic or laparoscopic) affected morbidity and mortality (de-
fined as the presence of any of the following outcomes:
30-day reoperation, 30-day readmission, anastomotic leak
and 30-day mortality). Following this, a multivariate model
was applied where surgical approach was adjusted for all clin-
ically relevant variables including age, gender, neoadjuvant
radiotherapy, ASA grade (I-II vs III-IV) and p T stage (T0–2
vs T3–4). The constant was included in the analysis model,
and data is presented as odds ratio, 95% confidence interval
and p value.
Results
A total of 222 obese patients received elective minimally in-
vasive rectal cancer resection surgery (63 robotic, 159 laparo-
scopic). The 63 robotic cases were propensity score matched
with 61 laparoscopic cases to reduce the effect of confounding
factors in the analysis.
Cohort characteristics
There were no differences in any of the cohort characteristic
data retrieved for the two cohorts as Table 1 shows. Patients
were matched for ASA grade, neoadjuvant radiotherapy and p
T stage.
Peri-operative characteristics and outcomes
The peri-operative characteristics of the two groups are
summarised in Table 2. Median operation time was greater
in the robotic cohort (260 vs 215 min; p = 0.000). Blood loss
and conversion rate were similar between the two cohorts.
There were only two conversions to open, both in the laparo-
scopic group. The first patient had high ventilation pressures
and was unable to tolerate the Trendelenburg position and
pneumoperitoneum meaning an early conversion was under-
taken. The second patient provided a challenge in access and
exposure due to excessive visceral fat.
Post-operative clinical and pathological outcomes
Length of stay was shorter (6 vs 8 days; p = 0.014) and 30-day
readmission rate lower (6.3% vs 19.7%; p = 0.033) in the ro-
botic surgery arm of this study. There were no differences in
any of the remaining post-operative clinical data (length of
stay, 30-day readmission rate, 30-day reoperation rate, anas-
tomotic leak rate, 30-day mortality rate) or pathological out-
comes (lymph node yield and R0 clearance) between the two
cohorts as summarised in Table 3.
There were four readmissions in the robotic cohort, these
were due to the following: a patient with a wound dehiscence,
a patient with a urinary tract infection and two patients with
ileus. In the laparoscopic group, there were 12 readmissions
due to a variety of reasons including the following: two pa-
tients admitted with non-specific abdominal pain, a patient
with an infected haematoma, four patients with ileus, three
patients with wound infections, one of which had a wound
dehiscence and two patients with high stoma outputs admitted
with dehydration. There were only two reoperations, both in
the laparoscopic group. Indications included a patient with a
malfunctioning stoma and a patient with a wound dehiscence.
Logistic regression analysis
Univariate logistic regression analysis of all 222 cases showed
that surgical approach did not affect morbidity and mortality
for the participants in this study, even though this did approach
statistical significance (p = 0.051). This was still the case in
multivariate analysis when other clinically relevant factors
were adjusted for (age, gender, neoadjuvant radiotherapy,
ASA grade, p T stage) as detailed in Table 4 (p = 0.072).
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Discussion
The effect of robotic rectal cancer surgery in offering superior
short-term outcomes in obese patients when compared to lap-
aroscopy is largely hitherto unknown. Several studies indicate
that obesity is a risk factor for worse short-term surgical out-
comes in laparoscopic colorectal surgery [27–29]. However,
this is still a subject of debate, with numerous studies demon-
strating no difference in short-term outcomes between laparo-
scopic obese and non-obese colorectal surgery patients [30,
31]. Nevertheless, the role of robotic colorectal surgery in
obese patients has only been investigated in a handful of stud-
ies [9, 18, 19, 32, 33], with only two comparing the outcomes
of obese robotic vs laparoscopic rectal surgery patients [18,
19]. The remaining three studies compared the outcomes of
obese versus non-obese patients receiving robotic rectal sur-
gery, with all three studies demonstrating no difference in
short-term outcomes between obese and non-obese patients
[9, 32, 33].
In the study presented here, both the length of stay and
30-day readmission rate were lower in patients receiving ro-
botic surgery while operation time was longer. However, there
were no differences in any of the remaining short-term surgi-
cal outcomes between robotic and laparoscopic rectal surgery.
Furthermore, surgical approach, whether robotic or laparo-
scopic, was not found to affect morbidity and mortality. This
study demonstrates that robotic rectal surgery in the obese is
both safe and feasible with results suggesting a quicker recov-
ery and better short-term readmission profile when compared
to laparoscopic surgery in obese patients.
Robotic systems offer superior stable 3D views and ergo-
nomic wristed instruments which are particularly useful when
operating in confined spaces such as the pelvis, making the
robotic platform especially attractive for rectal surgery. Obese
Table 1 Cohort characteristics
Robotic (n = 63) Laparoscopic (n = 61) p value
Mean age ± SD 65.80 67.25 0.469t
Median BMI (IQR) 32 (30–35.7) 32 (30–34) 0.372m
Gender
• male 40 (63.5%) 41 (67.2%) 0.663c
• female 23 (36.5%) 20 (32.8%)
ASA grade
• I 0 1 (1.6%) 0.523c
• II 47 (75.8%) 43 (70.5%)
• III 15 (24.2%) 17 (27.9%)
Procedure
• High anterior resection 12 (19%) 13 (21.3%) 0.842c
• Low anterior resection 42 (66.7%) 37 (60.7%)
• APER 8 (12.7%) 10 (16.4%)
• Hartman’s 1 (1.6%) 1 (1.6%)
Neoadjuvant radiotherapy 24 (38.1%) 14 (23%) 0.067c
p T stage
• 0 5 (7.9%) 2 (3.3%) 0.403c
• 1 4 (6.3%) 9 (14.8%)
• 2 19 (30.2%) 21 (34.4%)
• 3 33 (52.4%) 28 (45.9%)
• 4 2 (3.2%) 1 (1.6%)
t t test, mMann-Whitney U, c Chi square, SD standard deviation, BMI body mass index, IQR interquartile range,
ASA American Society of Anaesthesiology, APER abdominoperineal resection, p T stage pathological tumour
stage
Table 2 Peri-operative
characteristics and outcomes Robotic (n = 63) Laparoscopic (n = 61) p value
Median operative time in minutes (IQR) 260 (214–310) 215 (192.5–252.5) 0.000m
Median estimated blood loss in ml (IQR) 17.5 (10–20) 10 (0–40) 0.152m
Conversion to open 0 2 (3.3%) 0.240f
Italics statistically significant
m Mann-Whitney U, f Fisher’s exact test, IQR interquartile range
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patients tend to have increased intra-pelvic fat, further
restricting access, room for manoeuvre and surgical field vis-
ibility. By further restricting the available space in the already
narrow pelvis, robotic platforms seem ideally suited for this
group of patients. This is supported by the initial results of the
ROLARR trial (NCT01196000), a large randomised control
trial comparing robotic to laparoscopic rectal surgery [34, 35].
Data from this trial was presented at the ASCRS and EAES
conferences in June 2015, where conversion rates were lower
in the robotic cohort in obese patients [36]. Considering this in
conjunction with the high conversion and CRM positive rates
in recent multi-centre randomised control trials investigating
the role of laparoscopic rectal surgery [12, 13], the role of
robotic rectal surgery in the obese patients clearly warrants
further investigation.
In a similar study to ours, Gorgun et al. [18] compared 29
robotic with 27 laparoscopic obese rectal surgery patients. In this
study, there was no statistically significant differences in opera-
tive time between the two groups, although operative times were
longer in both cohorts compared to our results (rob vs lap: 329
vs 295 min; p = 0.13). Similarly, Shiomi et al. [19] compared 52
robotic with 30 laparoscopic obese rectal surgery cases and
again found no difference in operative time (rob vs lap: 238 vs
252; p = 0.39). In our study, median operative time was 45 min
longer in the robotic group. This may in part be explained by the
inclusion of several cases where the surgeons and theatre teams
were still in the earlier stages of their learning curve, with active
training led by the senior surgeon (AP) being undertaken in a
number of the included cases. While all consecutive cases are
included in the robotic cohort (including all the initial cases at
each unit), the laparoscopic cases are selected from a much
larger pool spreading over a longer period.
Early studies involving robotic rectal surgery demonstrated
that a significant contributor to the prolonged operation time in
robotic surgery was due to the time it took to dock and undock
the robot, which in part, may have been due to the relative
inexperience of the surgeon and theatre staff who were still
on the early stages of their learning curve [37–42]. More recent
studies report equivalent operation times between robotic and
laparoscopic rectal surgery [43–46] with some even demon-
strating shorter operation times for robotic surgery [47–50].
Furthermore, the laser target system and improved design of
the da Vinci Xi (the latest model by Intuitive Surgical) make
docking easier and faster and increase the feasibility of the
single docking approach. These features are likely to help fur-
ther reduce robotic rectal surgery operative times [51].
Furthermore, our results show that the median length of
stay was 2 days shorter, and 30-day readmission rate was
lower in the robotic cohort. This could be secondary to lower
post-operativemorbidity. Morbidity was assessed in this study
by analysing readmission, reoperation and anastomotic leak
rates. However, minor post-operative complications were not
included (Clavien-Dindo 1–2) as these were not reported in
the datasets. It is postulated that minor complications
Table 4 Univariate and multivariate logistic regression for morbidity and mortality
Univariate Multivariate
OR 95% CI lower 95% CI upper p value OR 95% CI lower 95% CI upper p value
Approach (rob vs lap) 2.698 0.996 7.305 0.051 2.651 0.917 7.659 0.072
Age 0.978 0.945 1.011 0.188 0.972 0.937 1.008 0.120
Gender (male vs female) 1.283 0.602 2.736 0.518 1.338 0.614 2.914 0.464
Neoadjuvant RT 1.722 0.570 5.203 0.335 1.238 0.377 4.071 0.725
ASA grade (I-II vs III-IV) 0.753 0.343 1.653 0.480 0.635 0.277 1.457 0.284
p T stage (T0–2 vs T3–4) 1.158 0.562 2.386 0.691 1.172 0.559 2.455 0.675
OR odds ratio, CI confidence interval, RT radiotherapy, ASA American Society of Anaesthesiology, p T stage pathological tumour stage
Table 3 Post-operative clinical
and pathological outcomes Robotic (n = 63) Laparoscopic (n = 61) p value
Median length of stay in days (IQR) 6 (5–8) 8 (6–14) 0.014m
30-day readmission 4 (6.3%) 12 (19.7%) 0.033f
30-day reoperation 0 2 (3.3%) 0.240f
30-day mortality 0 0
Anastomotic leak 1 (1.9%) 0 1.000f
Mean lymph node yield ± SD 17 (13–23.25) 16 (12–23.5) 0.639m
R0 clearance 61 (96.8%) 60 (98.4%) 1.000f
Italics statistically significant
m Mann-Whitney U, c Chi square, f Fisher’s exact test, IQR interquartile range, SD standard deviation
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(Clavien-Dindo 1–2) may be reflected in a prolonged hospital
stay, which may explain why length of stay was higher in the
laparoscopic group. In addition, readmission rates tend to be
higher when length of stay is shorter, since patients that are
discharged early are more likely to be readmitted with com-
plications that were not picked up during their original hospi-
tal stay. Considering that both length of stay and readmission
rate were lower in the robotic group, it is reasonable to suggest
that this may be due to reduced surgical morbidity. This is
supported by two recent studies published by the Cleveland
clinic group who reported that length of stay, readmission rate
and mortality effectively predict complications [52, 53].
Considering that mortality was equal between the two groups
in our study, these studies strengthen our argument that the
reduced readmission rate and length of stay in the robotic
cohort are due to a lower surgical morbidity profile.
It is worth noting that bothGorgun et al. [18] and Shiomi et al.
[19] also demonstrated a reduced length of stay in the robotic
groupwhen compared to the laparoscopic cohort (Gordun et al: 6
vs 8 days, p= 0.02; Shiomi et al: 7 vs 9 days, p < 0.001). Both
studies found that length of stay was shorter by 2 days in the
robotic group, with Shiomi et al. also demonstrating that blood
loss and complication rates were lower in the robotic cohort
(blood loss: 10.5 vs 34 ml, p = 0.002; complication rate: 9.6 vs
30%, p = 0.04). Considering the results of these studies in con-
junction with our results, it is conceivable that robotic rectal
surgery in the obese can lead to a quicker recovery and reduced
morbidity when compared to laparoscopic surgery.
Notwithstanding operative time, length of stay and read-
mission rate, there were no other differences in the examined
short-term outcomes. Furthermore, in logistic regression anal-
ysis, surgical approach (robotic or laparoscopic) was not
found to affect morbidity and mortality. However, we should
note that the p value neared statistical significance in both
univariate and multivariate analysis (univariate p = 0.051,
multivariate p = 0.072) when examining whether surgical ap-
proach affects morbidity and mortality (Table 4). In the ab-
sence of a power calculation being performed, we need to
acknowledge the risk of a type 2 error, and therefore, the p
value might have been significant if a higher number of pa-
tients were recruited.
Our results support the feasibility and safety of robotic
rectal surgery in obese patients. In the robotic group, there
was no conversion, 30-day mortality or reoperation, and the
estimated blood loss was very low. Furthermore, regarding the
short-term pathological results, the lymph node yield was ac-
ceptable and the CRM margin was negative (R0) in 96.8% of
robotic cases, which is superior to that reported in the recent
laparoscopic rectal surgery trials (ALaCaRT [12]: lap 93%,
open 97%; ACOSOG Z6051 [13]: lap 87.9%, open 92.3%).
Additionally, there is perception in the surgical community
that prolonged operative times are associated with worse
short-term outcomes [54], especially in obese patients due to
the prolonged fixed Trendelenburg position. However, this
was not the case in our study, and our results suggest that
robotic rectal surgery in the obese can lead to similar
short-term outcomes and a quicker post-operative recovery
regardless of operative time.
The main strengths of our study are that data was collected
from three centres from two different countries and is contem-
porary data, rather than data collected as part of a study that
possibly includes an element of performance bias in surgical
trials [55]. In addition, due to the propensity score matching,
the two cohorts were evenly matched in terms of cohort char-
acteristics, strengthening our results. Additionally, as far as we
are aware, this study includes the largest sample size of its
kind. Acknowledging its limitations, our study is retrospective
in nature and does not report any functional or long-term data.
We should also note that all the laparoscopic procedures
pre-dated the robotic cases and this could introduce an ele-
ment of bias in our results. However, we believe this is un-
likely since the two surgeons with the longest laparoscopic
colorectal practice had completed laparoscopic colorectal fel-
lowships, were experienced laparoscopic surgeons from the
outset of their practice and were both trainers for the
National Training Programme for Laparoscopic Colorectal
Surgery (LAPCO) in the UK [56]. Furthermore, the robotic
cohort is more likely to be affected by the learning curve of the
surgeons, since all initial cases are included. In addition, the
laparoscopic cases underwent the same standardised enhanced
recovery programme which was later applied to all the robotic
cases. As a result, we believe that by standardising
peri-operative care, both groups are comparable and
peri-operative care is unlikely to act as a confounding factor
when assessing hospital length of stay.
In summary, robotic rectal surgery in the obese could lead
to a quicker recovery and improved morbidity profile when
compared to laparoscopy, despite being associated with a lon-
ger operative time. Larger-scale multi-centre prospective ob-
servational studies are required to further investigate this top-
ic. In addition, urogenital function and long-term oncological
data need to be included in these studies to illuminate a more
holistic comparison.
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